Anti-Ischemic Agents
SKU
MRR-8E22B6193309
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 355.88 million
2030
USD 543.43 million
2024
USD 378.99 million
CAGR
6.23%
Anti-Ischemic Agents Market by Type (Antiplatelet Agents, Calcium Channel Blockers, Organic Nitrates), Indication (Angina Pectoris, Ischemic Stroke, Myocardial Infarction), Route of Administration, End-User - Global Forecast 2024-2030

[185 Pages Report] The Anti-Ischemic Agents Market size was estimated at USD 355.88 million in 2023 and expected to reach USD 378.99 million in 2024, at a CAGR 6.23% to reach USD 543.43 million by 2030.

Anti-Ischemic Agents Market
To learn more about this report, request a free sample copy
Anti-ischemic agents are pharmaceuticals designed to improve blood flow and oxygen supply to the heart, thereby reducing or preventing ischemia, characterized by restricted blood flow and oxygen to tissues. These agents are essential in managing angina pectoris, myocardial infarction, and peripheral arterial disease. The primary drivers include an aging population, the prevalence of cardiovascular diseases, technological advancements in drug development, and rising health awareness and healthcare expenditure. Additionally, the development of novel agents with fewer side effects and a longer duration of action propels its need. Key restraints involve stringent regulatory requirements, high costs associated with research and development, and potential side effects of anti-ischemic medications. Patent expirations resulting in the entry of generic drugs pose significant challenges by reducing the overall revenue generated from patented medications. Challenges include overcoming drug resistance, improving the clinical outcomes of patients with severe ischemic conditions, and addressing unmet medical needs in underserved populations. Additionally, balancing efficacy with minimal side effects remains a critical challenge. Opportunities exist in the form of increased investment in R&D for developing more effective and safer treatments, expanding into emerging markets, and personalizing therapy based on genetic profiling. Innovation in drug delivery systems presents a significant opportunity.
Anti-Ischemic Agents Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anti-Ischemic Agents Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anti-Ischemic Agents Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anti-Ischemic Agents Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, AstraZeneca, Baxter, Inc., Bayer AG, Boehringer Ingelheim, Bristol Myers Squibb, Cipla Ltd., Dr Reddy's Laboratories Ltd., Eli Lily & Company, Eris Lifesciences Ltd., FDC Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Ipca Laboratories Ltd., J B Chemicals and Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Pvt Ltd., Medley Pharmaceuticals Ltd., Micro Labs Ltd., Natco Pharma Ltd., Novartis AG, Pfizer, Inc., Torrent Pharmaceuticals Ltd., Troikaa Pharmaceuticals Ltd., and Zydus Lifesciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Anti-Ischemic Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Antiplatelet Agents
    • Calcium Channel Blockers
    • Organic Nitrates
    • Potassium Channel Openers
    • β-Blockers
  • Indication
    • Angina Pectoris
    • Ischemic Stroke
    • Myocardial Infarction
    • Peripheral Artery Diseases
  • Route of Administration
    • Intravenous (IV)
    • Oral
    • Transdermal
  • End-User
    • Ambulatory Care
    • Homecare
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Anti-Ischemic Agents Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anti-Ischemic Agents Market?
  3. What are the technology trends and regulatory frameworks in the Anti-Ischemic Agents Market?
  4. What is the market share of the leading vendors in the Anti-Ischemic Agents Market?
  5. Which modes and strategic moves are suitable for entering the Anti-Ischemic Agents Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageANTI-ISCHEMIC AGENTS MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. ANTI-ISCHEMIC AGENTS MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. ANTI-ISCHEMIC AGENTS MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionANTI-ISCHEMIC AGENTS MARKET SIZE, 2018-2030 (USD MILLION)ANTI-ISCHEMIC AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
    2. Anti-Ischemic Agents Market, by RegionANTI-ISCHEMIC AGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsANTI-ISCHEMIC AGENTS MARKET DYNAMICS
      1. Drivers
        1. Changing lifestyles and rising prevalence of ischemic conditions
        2. Increasing utilization of advanced diagnostic tools and techniques for ischemic conditions
        3. Surge in research activities for developing new anti-ischemic agents
      2. Restraints
        1. High cost of treatment
      3. Opportunities
        1. Ongoing innovations and investment in drug development activities
        2. Collaborative efforts among various stakeholders for clinical trials
      4. Challenges
        1. Associated side-effects and safety concerns
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Anti-Ischemic Agents Market, by Type
    1. IntroductionANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
    2. Antiplatelet AgentsANTI-ISCHEMIC AGENTS MARKET SIZE, BY ANTIPLATELET AGENTS, BY , 2018-2030 (USD MILLION)
    3. Calcium Channel BlockersANTI-ISCHEMIC AGENTS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY , 2018-2030 (USD MILLION)
    4. Organic NitratesANTI-ISCHEMIC AGENTS MARKET SIZE, BY ORGANIC NITRATES, BY , 2018-2030 (USD MILLION)
    5. Potassium Channel OpenersANTI-ISCHEMIC AGENTS MARKET SIZE, BY POTASSIUM CHANNEL OPENERS, BY , 2018-2030 (USD MILLION)
    6. β-BlockersANTI-ISCHEMIC AGENTS MARKET SIZE, BY Β-BLOCKERS, BY , 2018-2030 (USD MILLION)
  7. Anti-Ischemic Agents Market, by Indication
    1. IntroductionANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
    2. Angina PectorisANTI-ISCHEMIC AGENTS MARKET SIZE, BY ANGINA PECTORIS, BY , 2018-2030 (USD MILLION)
    3. Ischemic StrokeANTI-ISCHEMIC AGENTS MARKET SIZE, BY ISCHEMIC STROKE, BY , 2018-2030 (USD MILLION)
    4. Myocardial InfarctionANTI-ISCHEMIC AGENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY , 2018-2030 (USD MILLION)
    5. Peripheral Artery DiseasesANTI-ISCHEMIC AGENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASES, BY , 2018-2030 (USD MILLION)
  8. Anti-Ischemic Agents Market, by Route of Administration
    1. IntroductionANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
    2. Intravenous (IV)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INTRAVENOUS (IV), BY , 2018-2030 (USD MILLION)
    3. OralANTI-ISCHEMIC AGENTS MARKET SIZE, BY ORAL, BY , 2018-2030 (USD MILLION)
    4. TransdermalANTI-ISCHEMIC AGENTS MARKET SIZE, BY TRANSDERMAL, BY , 2018-2030 (USD MILLION)
  9. Anti-Ischemic Agents Market, by End-User
    1. IntroductionANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    2. Ambulatory CareANTI-ISCHEMIC AGENTS MARKET SIZE, BY AMBULATORY CARE, BY , 2018-2030 (USD MILLION)
    3. HomecareANTI-ISCHEMIC AGENTS MARKET SIZE, BY HOMECARE, BY , 2018-2030 (USD MILLION)
    4. HospitalsANTI-ISCHEMIC AGENTS MARKET SIZE, BY HOSPITALS, BY , 2018-2030 (USD MILLION)
  10. Americas Anti-Ischemic Agents Market
    1. Introduction
    2. AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ARGENTINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ARGENTINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)ARGENTINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)BRAZIL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)BRAZIL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)BRAZIL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)CANADA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CANADA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)CANADA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)MEXICO ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MEXICO ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)MEXICO ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  11. Asia-Pacific Anti-Ischemic Agents Market
    1. Introduction
    2. ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)AUSTRALIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AUSTRALIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)AUSTRALIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)CHINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CHINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)CHINA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)INDIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)INDIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)INDONESIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDONESIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)INDONESIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)JAPAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)JAPAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)JAPAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)MALAYSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MALAYSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)MALAYSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)PHILIPPINES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)PHILIPPINES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)PHILIPPINES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SINGAPORE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SINGAPORE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SINGAPORE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SOUTH KOREA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH KOREA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SOUTH KOREA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)TAIWAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TAIWAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)TAIWAN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)THAILAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)THAILAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)THAILAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)VIETNAM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)VIETNAM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)VIETNAM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  12. Europe, Middle East & Africa Anti-Ischemic Agents Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)DENMARK ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)DENMARK ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)DENMARK ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)EGYPT ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EGYPT ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)EGYPT ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)FINLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FINLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)FINLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)FRANCE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FRANCE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)FRANCE ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)GERMANY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)GERMANY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)GERMANY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ISRAEL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ISRAEL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)ISRAEL ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ITALY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ITALY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)ITALY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NETHERLANDS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NETHERLANDS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)NETHERLANDS ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NIGERIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NIGERIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)NIGERIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NORWAY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NORWAY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)NORWAY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)POLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)POLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)POLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)QATAR ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)QATAR ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)QATAR ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)RUSSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)RUSSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)RUSSIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SAUDI ARABIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SAUDI ARABIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SAUDI ARABIA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SOUTH AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SOUTH AFRICA ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SPAIN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SPAIN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SPAIN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SWEDEN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWEDEN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SWEDEN ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SWITZERLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWITZERLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)SWITZERLAND ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)TURKEY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TURKEY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)TURKEY ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED KINGDOM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED KINGDOM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)UNITED KINGDOM ANTI-ISCHEMIC AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  13. Competitive Landscape
    1. FPNV Positioning MatrixANTI-ISCHEMIC AGENTS MARKET, FPNV POSITIONING MATRIX, 2023ANTI-ISCHEMIC AGENTS MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerANTI-ISCHEMIC AGENTS MARKET SHARE, BY KEY PLAYER, 2023ANTI-ISCHEMIC AGENTS MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
  14. Competitive Portfolio
    1. Key Company Profiles
      1. Alembic Pharmaceuticals Limited
      2. AstraZeneca
      3. Baxter, Inc.
      4. Bayer AG
      5. Boehringer Ingelheim
      6. Bristol Myers Squibb
      7. Cipla Ltd.
      8. Dr Reddy's Laboratories Ltd.
      9. Eli Lily & Company
      10. Eris Lifesciences Ltd.
      11. FDC Ltd.
      12. Glenmark Pharmaceuticals Ltd.
      13. Intas Pharmaceuticals Ltd.
      14. Ipca Laboratories Ltd.
      15. J B Chemicals and Pharmaceuticals Ltd.
      16. Lupin Ltd.
      17. Macleods Pharmaceuticals Pvt Ltd.
      18. Medley Pharmaceuticals Ltd.
      19. Micro Labs Ltd.
      20. Natco Pharma Ltd.
      21. Novartis AG
      22. Pfizer, Inc.
      23. Torrent Pharmaceuticals Ltd.
      24. Troikaa Pharmaceuticals Ltd.
      25. Zydus Lifesciences Ltd.
    2. Key Product Portfolio
  1. Alembic Pharmaceuticals Limited
  2. AstraZeneca
  3. Baxter, Inc.
  4. Bayer AG
  5. Boehringer Ingelheim
  6. Bristol Myers Squibb
  7. Cipla Ltd.
  8. Dr Reddy's Laboratories Ltd.
  9. Eli Lily & Company
  10. Eris Lifesciences Ltd.
  11. FDC Ltd.
  12. Glenmark Pharmaceuticals Ltd.
  13. Intas Pharmaceuticals Ltd.
  14. Ipca Laboratories Ltd.
  15. J B Chemicals and Pharmaceuticals Ltd.
  16. Lupin Ltd.
  17. Macleods Pharmaceuticals Pvt Ltd.
  18. Medley Pharmaceuticals Ltd.
  19. Micro Labs Ltd.
  20. Natco Pharma Ltd.
  21. Novartis AG
  22. Pfizer, Inc.
  23. Torrent Pharmaceuticals Ltd.
  24. Troikaa Pharmaceuticals Ltd.
  25. Zydus Lifesciences Ltd.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Anti-Ischemic Agents Market
The Global Anti-Ischemic Agents Market size was estimated at USD 355.88 million in 2023 and expected to reach USD 378.99 million in 2024.
The Global Anti-Ischemic Agents Market to grow USD 543.43 million by 2030, at a CAGR of 6.23%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.